DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 158 filers reported holding DIPLOMAT PHARMACY INC in Q1 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,925,000 | -59.1% | 392,928 | -49.1% | 0.02% | -57.1% |
| Q2 2019 | $4,702,000 | -25.9% | 772,134 | -29.3% | 0.04% | -22.2% |
| Q1 2019 | $6,346,000 | -59.6% | 1,092,180 | -6.3% | 0.04% | -64.6% |
| Q4 2018 | $15,695,000 | -77.1% | 1,166,027 | -67.0% | 0.13% | -71.3% |
| Q3 2018 | $68,619,000 | +39.8% | 3,535,217 | +84.1% | 0.44% | +27.0% |
| Q2 2018 | $49,090,000 | -37.8% | 1,920,572 | -51.0% | 0.35% | -39.5% |
| Q1 2018 | $78,969,000 | +2.9% | 3,919,051 | +2.5% | 0.58% | +2.5% |
| Q4 2017 | $76,751,000 | -8.2% | 3,824,190 | -5.3% | 0.56% | -7.0% |
| Q3 2017 | $83,611,000 | -0.5% | 4,037,213 | -28.9% | 0.60% | -1.8% |
| Q2 2017 | $84,023,000 | -3.4% | 5,677,230 | +4.1% | 0.61% | -4.5% |
| Q1 2017 | $87,015,000 | – | 5,455,461 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |